Actualités Hemostemix Inc - HEM | Actions TSX Venture Exchange

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

InvestmentPitch Media Video Discusses Hemostemix and its Hiring of 4 Biotechnologists to Re-Establish Production of ACP-01 in Montreal and Applying for Grants to Fund Up to 75% of 5-Year Expenses

VANCOUVER, British Columbia, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Hemostemix Inc. (TSXV:HEM) (OTCQB:HMTXF...

InvestmentPitch Media Video Discusses Hemostemix and its $250,000 in Funding from McGill University Health Centre Foundation for Clinical Trial of ACP-01

VANCOUVER, British Columbia, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Hemostemix Inc. (TSXV:HEM) (OTCQB:HMTXF), an...

HEMOSTEMIX ANNOUNCES CLOSING OF UNIT PRIVATE PLACEMENT

HEMOSTEMIX ANNOUNCES CLOSING OF UNIT PRIVATE PLACEMENT May 10, 2021, Calgary, Alberta -- InvestorsHub...

Hemostemix Announces Completion of Phase II Clinical Trial Subject Follow Up & HMTXF Up-list

Hemostemix Announces Completion of Phase II Clinical Trial Subject Follow Up & HMTXF Up-list Calgary, Alberta, April 23, 2021-- InvestorsHub...

Hemostemix Announces a $2,500,000 Lead Order and its Clinical Trial and Litigation Updates

Hemostemix Announces a $2,500,000 Lead Order and its Clinical Trial and Litigation Updates Calgary, Alberta, April...

Hemostemix Announces it is Trading on the Frankfurt Stock Exchange and it has Retained HE Capital Markets Ltd.

Hemostemix Annonces it is Trading on the Frankfurt Stock Exchange and it has Retained HE Capital Markets LTD. Calgary...

Hemostemix Announces Corporate Update

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Feb...

Hemostemix Announces Corporate Update

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Feb...

Hemostemix Announces Corporate Update

CALGARY, Alberta, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV:...

Hemostemix Announces Financing Update and Secured Convertible Debenture Financing of Up to $2,000,000

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta...

Hemostemix Announces the Appointment of Dr. Ronnie Hershman to the Board of Directors and Provides a Corporate Update

CALGARY, Alberta, Feb. 10, 2020 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV:...

Hemostemix Provides Corporate Update and Clarification

CALGARY, Alberta, Jan. 26, 2020 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV:...

Hemostemix Announces Private Placement

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. CALGARY, Alberta...

Hemostemix Announces Corporate Update

CALGARY, Alberta, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX...

Hemostemix Announces Appointment of Director and Postponement of Annual and Special Meeting

CALGARY, Alberta, Dec. 02, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Hemostemix Inc (HEM)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

HEM Actualités

InvestmentPitch Media Video Discusses Hemostemix and its Hiring of 4 Biotechnologists to Re-Establish Production of ACP-01 in Montreal and Applying for Grants to Fund Up to 75% of 5-Year Expenses

InvestmentPitch Media Video Discusses Hemostemix and its $250,000 in Funding from McGill University Health Centre Foundation for Clinical Trial of ACP-01

HEMOSTEMIX ANNOUNCES CLOSING OF UNIT PRIVATE PLACEMENT

Hemostemix Announces Completion of Phase II Clinical Trial Subject Follow Up & HMTXF Up-list

Hemostemix Announces a $2,500,000 Lead Order and its Clinical Trial and Litigation Updates

Hemostemix Announces it is Trading on the Frankfurt Stock Exchange and it has Retained HE Capital Markets Ltd.

Hemostemix Announces Corporate Update

Hemostemix Announces Corporate Update

Hemostemix Announces Corporate Update

Hemostemix Announces Financing Update and Secured Convertible Debenture Financing of Up to $2,000,000

Hemostemix Announces the Appointment of Dr. Ronnie Hershman to the Board of Directors and Provides a Corporate Update

Hemostemix Provides Corporate Update and Clarification

Hemostemix Announces Private Placement

Hemostemix Announces Corporate Update

Hemostemix Announces Appointment of Director and Postponement of Annual and Special Meeting

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Hemostemix Inc (HEM) Actualités

Hemostemix Inc (HEM)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

HEM Actualités

InvestmentPitch Media Video Discusses Hemostemix and its Hiring of 4 Biotechnologists to Re-Establish Production of ACP-01 in Montreal and Applying for Grants to Fund Up to 75% of 5-Year Expenses

InvestmentPitch Media Video Discusses Hemostemix and its $250,000 in Funding from McGill University Health Centre Foundation for Clinical Trial of ACP-01

HEMOSTEMIX ANNOUNCES CLOSING OF UNIT PRIVATE PLACEMENT

Hemostemix Announces Completion of Phase II Clinical Trial Subject Follow Up & HMTXF Up-list

Hemostemix Announces a $2,500,000 Lead Order and its Clinical Trial and Litigation Updates

Hemostemix Announces it is Trading on the Frankfurt Stock Exchange and it has Retained HE Capital Markets Ltd.

Hemostemix Announces Corporate Update

Hemostemix Announces Corporate Update

Hemostemix Announces Corporate Update

Hemostemix Announces Financing Update and Secured Convertible Debenture Financing of Up to $2,000,000

Hemostemix Announces the Appointment of Dr. Ronnie Hershman to the Board of Directors and Provides a Corporate Update

Hemostemix Provides Corporate Update and Clarification

Hemostemix Announces Private Placement

Hemostemix Announces Corporate Update

Hemostemix Announces Appointment of Director and Postponement of Annual and Special Meeting

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application